64
Participants
Start Date
August 31, 2015
Primary Completion Date
September 5, 2018
Study Completion Date
September 5, 2018
Leuprolide Acetate 45 mg
Subcutaneous injection
The Liggins Institute, University of Auckland, Auckland
Nemours Children's Clinic, Jacksonville
Nemours Children's Hospital, Orlando
Joe DiMaggio Children's Hospital, Hollywood
Instituto de Investigaciones Aplicadas a la Neurociencia, A.C., Durango
Cincinnati Children's Hospital Medical Center, Endocrine, Cincinnati
Riley Hospital for Children at Indiana University Health, Indianapolis
University of Minnesota, Minneapolis
"Hospital Unversitario Dr. Jose Eleuterio Gonzalez", Monterrey
University of Oklahoma College of Medicine, Tulsa
University of California, San Diego, San Diego
Seattle Children's, Seattle
MultiCare Institute for Research and Innovation, Tacoma
Hospital Regional de Antofagasta Leonardo Guzman, Antofagasta
Pontificia Universidad Catolica de Chile, Santiago
Instituto de Investigaciones Materno Infantil (IDIMI), Santiago
Hospital de Ninos, Buenos Aires
University of Calgary, Alberta Children's Hospital, Calgary
McGill University Health Centre, Montreal
CHU de Quebec-Universite Laval, Québec
Tolmar Inc.
INDUSTRY